An update on Helicobacter pylori microbiology and infection for the new millennium

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 3, 2001, Pages 163-174

  Enroth, H ^a   Engstrand, L ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; ESCHERICHIA COLI ENDOTOXIN; HELICOBACTER PYLORI VACCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOLOGICAL ADJUVANT; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTEIN; TETRACYCLINE; UREA; UREASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; BACTERIUM; BREATH ANALYSIS; CLINICAL TRIAL; COMPLEMENT FIXATION; DISEASE MARKER; DISEASE TRANSMISSION; ENDOSCOPY; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FAMILY; GENETICS; GENOME; GENOTYPE; GRAM NEGATIVE INFECTION; GRAM STAINING; HELICOBACTER PYLORI; HEREDITY; HISTOLOGY; HOST CELL; HUMAN; HYPOTHESIS; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; LATEX AGGLUTINATION TEST; MICROBIOLOGY; NONHUMAN; PATHOGENICITY; PEPTIC ULCER; PHENOTYPE; POLYMERASE CHAIN REACTION; REVIEW; RHESUS MONKEY; STOMACH DISEASE; STRAIN DIFFERENCE; SWINE; SYMPTOM; TREATMENT OUTCOME; WESTERN BLOTTING;

AGE FACTORS; BACTERIAL ADHESION; BACTERIAL VACCINES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; VIRULENCE;

EID: 0035084633     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540151060725     Document Type: Review

References (128)

1. A century of Helicobacter pylori. Paradigms lost - Paradigms regained
2. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
3. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report
4. Helicobacter pylori
5. Helicobacter-species classification and identification
6. Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa
7. Bacterium-host interactions monitored by time-lapse photography
8. Signal transduction-mediated adherence and entry of Helicobacter pylori into cultured cells
9. Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
10. The role of Helicobacter species in newly recognized gastrointestinal tract diseases of animals
11. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: Pathogenesis and definition of gastric atrophy
12. Precancerous lesions in two counties of China with contrasting gastric cancer risks
13. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the east
14. Review article: Is there significant variation in the risk of gastric cancer associated with Helicobacter pylori infection?
15. Helicobacter pylori and gastric cancer
16. Review article: Exploring the link between Helicobacter pylori and gastric cancer
17. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
18. Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis
19. Helicobacter pylori infection and gastric cancer: Systematic review of the epidemiological studies
20. Is Helicobacter pylori really the cause of gastric cancer?
21. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
22. Is Helicobacter pylori really the cause of gastroduodenal disease?
23. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model
24. pylori and cagA: Relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications
25. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease
26. Review article: The role of inflammation in the pathogenesis of gastric cancer
27. Helicobacter pylori as a pathogen and carcinogen
28. Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis
29. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide
30. Correlation between epithelial cell proliferation and histological grading in gastric mucosa
31. Microflora of gastric biopsies from patients with duodenal ulcer and gastric cancer. A comparative study of patients from Korea, Colombia and the United States
32. How is Helicobacter pylori transmitted?
33. Epidemiology of Helicobacter pylori: Acquisition, transmission, population prevalence and disease-to-infection ratio
34. Risk of Helicobacter pylori infection among long-term residents in developing countries
35. Familial clustering of Helicobacter pylori infection: Population based study
36. Age distribution of Helicobacter pylori seroprevalence among young children in a United States/Mexico border community: Evidence for transitory infection
37. Low rates of Helicobacter pylori reinfection in children
38. Inverse graded relation between alcohol consumption and active infection with Helicobacter pylori
39. Acquisition versus loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
40. Host determinants of Helicobacter pylori infection and its clinical outcome
41. Co-twin study of the effect of environment and dietary elements on acquisition of Helicobacter pylori infection
42. Epidemiology of Helicobacter pylori infection with special reference to professional risk
43. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection
44. HLA-DQA1 alleles and the presence of Helicobacter pylori antibodies
45. Host specificity of Helicobacter pylori strains and host responses in experimentally challenged non-human primates
46. Helicobacter pylori-associated gastritis in mice is host and strain specific
47. Active infection with Helicobacter pylori in healthy couples
48. Uses and cautions for use of polymerase chain reaction for detection of Helicobacter pylori
49. Determinants of Helicobacter pylori pathogenicity
50. A review of the possible bacterial determinants of clinical outcome in Helicobacter pylori infection
51. Epithelial attachment alters the outcome of Helicobacter pylori infection
52. Biofilm formation by Helicobacter pylori
53. Virulence and colonization-associated properties of Helicobacter pylori isolated from children and adolescents
54. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging
55. Bugs on trial: The case of Helicobacter pylori and autoimmunity
56. Phenotypic diversity in Lewis expression of Helicobacter pylori isolates from the same host
57. H. pylori virulence factors
58. Pathogenicity island mediates Helicobacter pylori interaction with the host
59. Helicobacter pylori - A conundrum of genetic diversity
60. Emergence of recombinant strains of Helicobacter pylori during human infection
61. The complete genome sequence of the gastric pathogen Helicobacter pylori
62. The Helicobacter pylori genome - New insights into pathogenesis and therapeutics
63. From genes to genome biology: A new era in Helicobacter pylori research
64. Metabolism and genetics of Helicobacter pylori: The genome era
65. First food-borne pathogen sequenced
66. Free recombination within Helicobacter pylori
67. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
68. Evolution of Helicobacter pylori: The role of recombination
69. Pathoadaptive mutations: Gene loss and variation in bacterial pathogens
70. Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution
71. Type I Helicobacter pylori shows Lewis b independent adherence to gastric cells requiring de novo protein synthesis in both host and bacteria
72. Helicobacter pylori - Molecular genetics and diagnostic typing
73. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains
74. Detection of anti-VacA antibody responses in serum and gastric juice samples using type s1/m1 and s2/m2 Helicobacter pylori VacA antigens
75. Vacuolating toxin gene polymorphism among Helicobacter pylori clinical isolates and its association with m1, m2 or chimeric vacA middle types
76. Failure to confirm association of vacA gene mosaicism with duodenal ulcer disease
77. Analysis of vacA, cagA and IS605 genotypes and those determined by PCR amplification of DNA between repetitive sequences of Helicobacter pylori strains isolated from patients with non-ulcer dyspepsia or tissue lymphoma
78. Geographic distribution of vacA allelic types of Helicobacter pylori
79. Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes
80. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains
81. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis
82. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers
83. Detection and characterization of Helicobacter pylori from patients with gastroduodenal diseases
84. Genomic fingerprinting of clinical isolates of Helicobacter pylori by REP-PCR and restriction fragment end-labelling
85. Relationships between Helicobacter pylori iceA, cagA and vacA status and clinical outcome: Studies in four different countries
86. Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori
87. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers
88. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with originating from Europe and Africa
89. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
90. Cytotoxin-associated gene-A-positive Helicobacter pylori infection in the elderly. Association with gastric atrophy and intestinal metaplasia
91. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: The role of CagA status
92. Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: An international study
93. vacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori
94. One stomach-one strain: Does Helicobacter pylori strain variation influence disease outcome?
95. DNA fingerprinting of single colonies of Helicobacter pylori from gastric cancer patients suggests infection with a single predominant strain
96. REP-PCR fragments as biomarkers for differentiating gastroduodenal disease-specific Helicobacter pylori strains
97. Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease
98. Use of gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients
99. Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material
100. Review article: Practical management issues for the Helicobacter pylori-infected patient at risk of gastric cancer
101. Getting to the route of Helicobacter pylori treatment
102. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
103. Helicobacter pylori, acid, and omeprazole revisited: Bacterial eradication and rebound hypersecretion
104. Treatment of Helicobacter pylori: Future therapeutic and prophylactic perspectives
105. Helicobacter pylori - Reflections for the next millennium
106. Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates
107. Antibiotic resistance in Helicobacter pylori: Implications for therapy
108. Clinical relevance of resistant strains of Helicobacter pylori: A review of current data
109. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori
110. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens
111. Occurrence of resistance mutation and clonal expansion in Helicobacter pylori multiple strain infection - A potential risk in clarithromycin based therapy?
112. Vaccine development against infection with Helicobacter pylori
113. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice
114. Vaccination of gnotobiotic piglets against Helicobacter pylori
115. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
116. Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by 'proteome' technologies
117. Clustering of clinical strains of Helicobacter pylori when analyzed by two-dimensional gel electrophoresis (2-D PAGE)
118. Helicobacter pylori virulence and genetic geography
119. Infectious causes of chronic inflammatory diseases and cancer
120. In a world of black and white, Helicobacter pylori is gray
121. Helicobacter pylori factors associated with disease
122. Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications
123. Antibacterial peptide from H. pylori
124. Prospects for therapeutic Helicobacter pylori vaccines
125. Working towards a Helicobacter pylori vaccine
126. Helicobacter pylori infection in man: Problems to be solved
127. Science, medicine, and the future. Helicobacter pylori and gastric diseases
128. Helicobacter pylori and the future: An afterword